Rexulti 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFH4S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,749
Award facts
- Contract value 100% obligated
- $17,749.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,749.33 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Rexulti 2 mg tablets (30-count packages). This firm fixed-price contract is classified as non-competitive and carries an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a critical vendor within the federal medical supply chain, regularly fulfilling delivery orders for brand-name and generic pharmaceuticals through DLA's competitive procurement processes. The company's extensive contract portfolio demonstrates its capability to supply diverse therapeutic products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This procurement of Rexulti supports the ongoing pharmaceutical needs of the military medical supply chain and represents routine execution under the company's existing prime vendor agreement.
Quick answers
Who was awarded contract SPE2DR26FFH4S?
SPE2DR26FFH4S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FFH4S worth?
The government has obligated $17,749 on SPE2DR26FFH4S.
Is contract SPE2DR26FFH4S an order under another contract?
Yes. SPE2DR26FFH4S is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFH4S competed?
The extent of competition for SPE2DR26FFH4S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award